PW
VRTX icon

Price Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

Price Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$20K Buy
73
+44
+152% +$12.1K 0.01% 190
2020
Q2 		$8K Buy
29
+23
+383% +$6.24K ﹤0.01% 197
2020
Q1 		$1K Buy
+6
New +$1.38K ﹤0.01% 387
2018
Q3 		– Sell
-72
Closed -$12K – 431
2018
Q2 		$12K Buy
72
+57
+380% +$8.84K ﹤0.01% 280
2018
Q1 		$2K Sell
15
-15
-50% -$2.45K ﹤0.01% 311
2017
Q4 		$4K Buy
+30
New +$4.44K ﹤0.01% 266

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Price Wealth's VRTX Position: Q3 2020 in Review

Price Wealth increased its Vertex Pharmaceuticals (VRTX) stake by 152% in Q3 2020, buying an estimated $12.1K and bringing the position to 73 shares worth $20K. The position accounts for 0.01% of the portfolio, ranked #190.

Price Wealth first reported a position in VRTX in Q4 2017 and has held it in 6 quarters since. 950 funds tracked by Wall St. Rank hold VRTX as of Q3 2020.

  • Price Wealth held 73 shares of Vertex Pharmaceuticals worth $20K as of Q3 2020.
  • Price Wealth bought 44 Vertex Pharmaceuticals shares in Q3 2020, an estimated $12.1K.
  • Vertex Pharmaceuticals made up 0.01% of Price Wealth's portfolio in Q3 2020, its #190 holding.
  • Price Wealth first reported a position in Vertex Pharmaceuticals in Q4 2017 and has held it in 6 quarters since.
  • 950 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2020.

Based on Price Wealth's 13F filing for Q3 2020, filed 22 Oct 2020.